In this We Play It Forward segment, we’re exploring a breakthrough story making international headlines — can FDA-approved cancer drugs actually reverse Alzheimer’s disease? Joining us to unpack the science is Dr. Nathan Bryan, Founder and CEO of Bryan Therapeutics, a company leading the charge in nitric oxide–based therapies.
Dr. Bryan explains how decades of research into nitric oxide, the molecule essential for healthy brain and vascular function, may hold the key to stopping or even reversing Alzheimer’s progression. We’ll discuss where the medical world currently stands in the fight against neurodegenerative diseases, how nitric oxide impacts brain health and cognition, and what this groundbreaking discovery could mean for millions affected by Alzheimer’s.